Evidence map›Paper›PMID 34319852›Full record

ArticleThe Libyan journal of medicine2021

HER2 overexpression is a putative diagnostic and prognostic biomarker for late-stage colorectal cancer in North African patients.

Eman A Abdul Razzaq, Thenmozhi Venkatachalam, Khuloud Bajbouj, Mohamed Rahmani, Amena Mahdami, Surendra Rawat, Naziha Mansuri, Hussein Alhashemi, Rifat Akram Hamoudi, Riyad Bendardaf

Open access · goldAbstract read
In one paragraph

Article in The Libyan journal of medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. The Role of Beclin 1 and HER2 in Colorectal Carcinoma; An Immunohistochemical Study.Asian Pacific journal of cancer prevention : APJCP · 2024
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 3 countries.

Eman A Abdul RazzaqClinical Sciences Department, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates.
Thenmozhi VenkatachalamSharjah Institute for Medical Research, University of Sharjah, Sharjah, United Arab Emirates.
Khuloud BajboujClinical Sciences Department, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates.
Mohamed RahmaniClinical Sciences Department, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates.ORCID https://orcid.org/0000-0002-3992-8039
Amena MahdamiSharjah Institute for Medical Research, University of Sharjah, Sharjah, United Arab Emirates.ORCID https://orcid.org/0000-0002-3226-6933
Surendra RawatSharjah Institute for Medical Research, University of Sharjah, Sharjah, United Arab Emirates.ORCID https://orcid.org/0000-0002-7414-5865
Naziha MansuriDepartment of Pathology, University of Turku, Finland.ORCID https://orcid.org/0000-0002-1606-8478
Hussein AlhashemiDepartment of surgery NCI, Sabratha, Libya.
Rifat Akram HamoudiClinical Sciences Department, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates.ORCID https://orcid.org/0000-0002-1402-0868
Riyad BendardafClinical Sciences Department, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates.ORCID https://orcid.org/0000-0002-5158-4590
University of Sharjah · AEUniversity of Turku · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Colorectal NeoplasmsErb-b2 Receptor Tyrosine KinasesBiomarkers, TumorHumansImmunohistochemistryPrognosisBiomarkers, TumorErb-b2 Receptor Tyrosine KinasesCRCHER2IHC

Identifiers

PMID34319852
PMCPMC8330780
OpenAlexW3184309003

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.